5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile
Description
INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed worldwide to treat blood cancer and other life-threatening blood disorders. As successful transplantation requires an HLA-compatible donor, unrelated donor
